47 results on '"Brandt, Alexander"'
Search Results
2. sj-pdf-2-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
3. sj-docx-13-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
4. sj-docx-12-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
5. sj-docx-17-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
6. sj-docx-18-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
7. sj-docx-19-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
8. sj-docx-16-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
9. sj-docx-9-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
10. sj-docx-12-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
11. sj-docx-17-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
12. sj-pdf-3-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
13. sj-docx-8-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
14. sj-docx-14-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
15. sj-docx-8-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
16. sj-docx-15-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
17. sj-docx-18-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
18. sj-docx-19-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
19. sj-docx-11-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
20. sj-pdf-1-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
21. sj-docx-9-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
22. sj-pdf-2-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
23. sj-pdf-1-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
24. sj-docx-15-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
25. sj-pdf-4-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
26. sj-docx-16-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
27. sj-docx-10-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
28. sj-pdf-3-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
29. sj-pdf-2-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders
30. sj-pdf-1-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders
31. sj-pdf-2-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders
32. sj-pdf-4-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders
33. sj-pdf-3-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation
34. sj-pdf-1-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation
35. sj-pdf-4-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders
36. sj-pdf-2-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation
37. sj-pdf-1-mso-10.1177_2055217321998060 - Supplemental material for A novel investigation method for axonal damage in neuromyelitis optica spectrum disorder: In vivo corneal confocal microscopy
38. sj-pdf-1-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation
39. sj-pdf-1-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders
40. sj-pdf-3-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders
41. sj-pdf-1-mso-10.1177_2055217321998060 - Supplemental material for A novel investigation method for axonal damage in neuromyelitis optica spectrum disorder: In vivo corneal confocal microscopy
42. sj-pdf-3-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders
43. sj-pdf-3-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation
44. MSO915480 Supplemental Material - Supplemental material for Evaluation of the ‘ring sign’ and the ‘core sign’ as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis
45. MSO903474 Supplemental material - Supplemental material for High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial
46. Supplemental material for Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study
47. Supplemental Table2 - Supplemental material for Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.